Clear Evidence of Safety and Efficacy Is Needed for Stromal Vascular Fraction Products: Commentary on "Arguments for a Different Regulatory Categorization and Framework for Stromal Vascular Fraction".
作者信息
Marks Peter W
机构信息
Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
出版信息
Stem Cells Dev. 2020 Mar 1;29(5):263-265. doi: 10.1089/scd.2020.0011. Epub 2020 Feb 19.